No differences were observed among these groups with respect to age, duration of T2D, systolic blood pressure (SBP), diastolic blood pressure (DBP), BMI, history of smoking, statin use, use of other antidiabetic treatments, use of antihypertensive treatments, AUCCP, HOMA-IRCP, serum uric acid (UA) levels, cystatin C levels, eGFR, UACR, triglyceride (TG) levels, high-density lipoprotein cholesterol (HDL-C) levels, LDL-C levels, PTH levels, 25(OH)D levels, lumbar spine, and total hip BMDs, or the proportions of patients diagnosed with osteoporosis (all p > 0.05). The gene discussed is CST3; the disease is type 2 diabetes mellitus.